Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."
Tide Pharmaceutical (000590.SZ) announced that the Board of Directors has approved the proposal to change the company's name to "Guhan Pharmaceutical Group Co., Ltd." and to revise the company's articles of association. After the company name change is completed, the company will apply to the Shenzhen Stock Exchange for a change in its stock abbreviation in accordance with relevant regulations.
Tus-Pharmaceutical Group (000590.SZ) announced that the board of directors has approved the proposal to change the company's name to "Guhan Pharmaceutical Group Co., Ltd." and to revise the company's Articles of Association. After the name change is completed, the company will apply to the Shenzhen Stock Exchange for a change in the stock abbreviation in accordance with relevant regulations.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


